GLYC
Income statement / Annual
Last year (2024), GlycoMimetics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, GlycoMimetics, Inc.'s net income was $0.00.
See GlycoMimetics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$10,000.00 |
$74,925.00 |
$1.16 M |
$10.16 M |
$0.00 |
$0.00 |
$0.00 |
$18,000.00 |
$20.07 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$1.03 M
|
$1.01 M
|
$0.00
|
$899,302.00
|
$275,123.00
|
$263,541.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$10,000.00
|
-$957,231.00
|
$146,361.00
|
$10.16 M
|
-$899,302.00
|
-$275,123.00
|
-$263,541.00
|
$18,000.00
|
$20.07 M
|
| Gross Profit Ratio |
0
|
1
|
-12.78
|
0.13
|
1
|
0
|
0
|
0
|
1
|
1
|
| Research and Development Expenses |
$14.26 B
|
$20.07 M
|
$28.39 M
|
$47.49 M
|
$44.93 M
|
$47.03 M
|
$40.09 M
|
$24.10 M
|
$23.28 M
|
$25.05 M
|
| General & Administrative Expenses |
$18.25 B
|
$19.21 M
|
$19.09 M
|
$17.12 M
|
$16.74 M
|
$14.36 M
|
$11.41 M
|
$9.83 M
|
$8.65 M
|
$7.81 M
|
| Selling & Marketing Expenses |
$0.00
|
$637.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.25 B
|
$19.21 M
|
$19.09 M
|
$17.12 M
|
$16.74 M
|
$14.36 M
|
$11.41 M
|
$9.83 M
|
$8.65 M
|
$7.81 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.23 M
|
$651,212.00
|
$104,000.00
|
$15,000.00
|
| Operating Expenses |
$32.51 B
|
$39.29 M
|
$47.48 M
|
$64.61 M
|
$61.67 M
|
$61.39 M
|
$51.51 M
|
$33.93 M
|
$31.93 M
|
$32.86 M
|
| Cost And Expenses |
$40.04 B
|
$39.29 M
|
$47.48 M
|
$64.61 M
|
$61.67 M
|
$61.39 M
|
$51.51 M
|
$33.93 M
|
$31.93 M
|
$32.86 M
|
| Interest Income |
$935.28 M
|
$2.38 M
|
$715,000.00
|
$20,000.00
|
$482,000.00
|
$3.50 M
|
$3.23 M
|
$0.00
|
$0.00
|
$15,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$46.64 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$153,301.00
|
$1.03 M
|
$1.01 M
|
$951,599.00
|
$899,302.00
|
$275,123.00
|
$263,541.00
|
$190,540.00
|
$191,484.00
|
| EBITDA |
-$40.04 B |
-$39.12 M |
-$47.20 M |
-$63.18 M |
-$51.24 M |
-$56.99 M |
-$51.23 M |
-$33.67 M |
-$31.72 M |
-$12.59 M |
| EBITDA Ratio |
0
|
-3912.2
|
-632.67
|
-54.7
|
-5.07
|
0
|
0
|
0
|
-1773
|
-0.64
|
| Operating Income Ratio |
0
|
-3927.53
|
-632.67
|
-54.7
|
-5.07
|
0
|
0
|
0
|
-1773
|
-0.64
|
| Total Other Income/Expenses Net |
$0.00
|
$2.38 M
|
$714,520.00
|
$19,768.00
|
$482,487.00
|
$3.50 M
|
$3.23 M
|
$651,212.00
|
$103,647.00
|
$15,327.00
|
| Income Before Tax |
$0.00
|
-$36.90 M
|
-$46.69 M
|
-$63.43 M
|
-$51.03 M
|
-$57.89 M
|
-$48.27 M
|
-$33.28 M
|
-$31.81 M
|
-$12.77 M
|
| Income Before Tax Ratio |
0
|
-3689.94
|
-623.13
|
-54.68
|
-5.02
|
0
|
0
|
0
|
-1767.22
|
-0.64
|
| Income Tax Expense |
$0.00
|
-$637.00
|
$46.64 M
|
-$284,600.00
|
-$752,754.00
|
-$3.78 M
|
$3.23 M
|
$0.00
|
-$190,540.00
|
-$191,484.00
|
| Net Income |
$0.00
|
-$36.90 M
|
-$93.33 M
|
-$63.14 M
|
-$50.27 M
|
-$54.12 M
|
-$48.27 M
|
-$33.28 M
|
-$31.81 M
|
-$12.77 M
|
| Net Income Ratio |
0
|
-3689.94
|
-1245.63
|
-54.43
|
-4.95
|
0
|
0
|
0
|
-1767.22
|
-0.64
|
| EPS |
-0.59 |
-0.58 |
-1.78 |
-1.23 |
-1.1 |
-1.25 |
-1.18 |
-1.13 |
-1.5 |
-0.67 |
| EPS Diluted |
-0.59 |
-0.58 |
-1.78 |
-1.23 |
-1.1 |
-1.25 |
-1.18 |
-1.13 |
-1.5 |
-0.67 |
| Weighted Average Shares Out |
$64.48 M
|
$63.34 M
|
$52.53 M
|
$51.45 M
|
$45.72 M
|
$43.25 M
|
$41.04 M
|
$29.40 M
|
$21.26 M
|
$19.01 M
|
| Weighted Average Shares Out Diluted |
$64.48 M
|
$63.34 M
|
$52.53 M
|
$51.45 M
|
$45.72 M
|
$43.25 M
|
$41.04 M
|
$29.40 M
|
$21.26 M
|
$19.01 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
